Skip to main content
NIH funding notice PAR-15-307

Translational Studies on Adducts for Cancer Risk Identification and Prevention (U01)

Closed on July 11, 2018.

Posted
July 24, 2015
Close date
July 11, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $518,198 in first-year total cost, median $518,198.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-2 (J2)]1

Most frequent institutions

  1. GEORGETOWN UNIVERSITY1
Competing awards under PAR-15-307 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention1U01CA220477-01A1CHUNG, FUNG-LUNGHE, AIWU RUTHGEORGETOWN UNIVERSITY, DC$518,198ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-15-307: Translational Studies on Adducts for Cancer Risk Identification and Prevention (U01) | ScienceDex | ConductScience